SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

EPA:SABE • FR0000060121

21 EUR
0 (0%)
Last: Feb 19, 2026, 07:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SABE. SABE was compared to 59 industry peers in the Food Products industry. The financial health of SABE is average, but there are quite some concerns on its profitability. SABE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SABE had negative earnings in the past year.
  • In the past year SABE had a positive cash flow from operations.
  • SABE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SABE had a positive operating cash flow.
SABE.PA Yearly Net Income VS EBIT VS OCF VS FCFSABE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • SABE has a Return On Assets of -0.61%. This is in the lower half of the industry: SABE underperforms 74.58% of its industry peers.
  • Looking at the Return On Equity, with a value of -1.37%, SABE is doing worse than 72.88% of the companies in the same industry.
Industry RankSector Rank
ROA -0.61%
ROE -1.37%
ROIC N/A
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)N/A
ROIC(5y)N/A
SABE.PA Yearly ROA, ROE, ROICSABE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • In the last couple of years the Profit Margin of SABE has declined.
  • In the last couple of years the Operating Margin of SABE has declined.
  • With a Gross Margin value of 33.73%, SABE perfoms like the industry average, outperforming 47.46% of the companies in the same industry.
  • SABE's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SABE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.73%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
SABE.PA Yearly Profit, Operating, Gross MarginsSABE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

  • SABE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SABE has about the same amount of shares outstanding.
  • The number of shares outstanding for SABE has been reduced compared to 5 years ago.
  • The debt/assets ratio for SABE has been reduced compared to a year ago.
SABE.PA Yearly Shares OutstandingSABE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
SABE.PA Yearly Total Debt VS Total AssetsSABE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • SABE has an Altman-Z score of 1.85. This is not the best score and indicates that SABE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SABE has a Altman-Z score (1.85) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.67 indicates that SABE is somewhat dependend on debt financing.
  • The Debt to Equity ratio of SABE (0.67) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.85
ROIC/WACCN/A
WACC6.03%
SABE.PA Yearly LT Debt VS Equity VS FCFSABE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • SABE has a Current Ratio of 1.78. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.
  • SABE has a Current ratio of 1.78. This is in the better half of the industry: SABE outperforms 67.80% of its industry peers.
  • SABE has a Quick Ratio of 1.47. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.47, SABE belongs to the top of the industry, outperforming 81.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.47
SABE.PA Yearly Current Assets VS Current LiabilitesSABE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

  • The earnings per share for SABE have decreased strongly by -125.36% in the last year.
  • Measured over the past years, SABE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.41% on average per year.
  • SABE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.51%.
  • SABE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.46% yearly.
EPS 1Y (TTM)-125.36%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-186.25%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%-0.6%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SABE.PA Yearly Revenue VS EstimatesSABE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

  • SABE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SABE.PA Price Earnings VS Forward Price EarningsSABE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • SABE's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.57
SABE.PA Per share dataSABE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.50%, SABE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.53, SABE is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.81, SABE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

  • The dividend of SABE decreases each year by -14.70%.
Dividend Growth(5Y)-14.7%
Div Incr Years0
Div Non Decr Years2
SABE.PA Yearly Dividends per shareSABE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

  • The earnings of SABE are negative and hence is the payout ratio. SABE will probably not be able to sustain this dividend level.
  • The Dividend Rate of SABE has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-31.13%
EPS Next 2YN/A
EPS Next 3YN/A
SABE.PA Yearly Income VS Free CF VS DividendSABE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

SAINT JEAN GROUPE SA

EPA:SABE (2/19/2026, 7:00:00 PM)

21

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.41%
Ins Owner ChangeN/A
Market Cap67.20M
Revenue(TTM)116.46M
Net Income(TTM)-1.03M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.1
Dividend Growth(5Y)-14.7%
DP-31.13%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF 6.5
P/B 0.9
P/tB 0.98
EV/EBITDA 13.57
EPS(TTM)-0.32
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)3.23
OCFY15.39%
SpS36.39
BVpS23.43
TBVpS21.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -1.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.73%
FCFM N/A
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.67%
ROCE(5y)1.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 5.41
Cap/Depr 116.44%
Cap/Sales 11.75%
Interest Coverage N/A
Cash Conversion 111.38%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.47
Altman-Z 1.85
F-Score5
WACC6.03%
ROIC/WACCN/A
Cap/Depr(3y)230.83%
Cap/Depr(5y)238.47%
Cap/Sales(3y)16.15%
Cap/Sales(5y)16.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-125.36%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-186.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.51%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%-0.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-157.73%
EBIT growth 3Y-13.22%
EBIT growth 5Y-5.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.08%
OCF growth 3Y8.5%
OCF growth 5Y8.59%

SAINT JEAN GROUPE SA / SABE.PA FAQ

What is the ChartMill fundamental rating of SAINT JEAN GROUPE SA (SABE.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SABE.PA.


What is the valuation status of SAINT JEAN GROUPE SA (SABE.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to SAINT JEAN GROUPE SA (SABE.PA). This can be considered as Overvalued.


Can you provide the profitability details for SAINT JEAN GROUPE SA?

SAINT JEAN GROUPE SA (SABE.PA) has a profitability rating of 2 / 10.


How financially healthy is SAINT JEAN GROUPE SA?

The financial health rating of SAINT JEAN GROUPE SA (SABE.PA) is 4 / 10.